Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-14 12:29 pm Purchase | 13G | Clarus Therapeutics Holdings Inc. CRXT | ARMISTICE CAPITAL LLC | 2,732,169 4.990% | 279,793 (+11.41%) | View |
| 2022-07-06 4:00 pm Unchanged | 13G | Clarus Therapeutics Holdings Inc. CRXT | Bracebridge Capital LLC | 2,002,495 54.000% | 0 (Unchanged) | View |
| 2022-04-21 8:43 pm Sale | 13D | Clarus Therapeutics Holdings Inc. CRXT | Thomas McNerney & Partners LLC | 45,659 0.200% | -5,452,912 (-99.17%) | View |
| 2022-02-14 6:22 pm Purchase | 13G | Clarus Therapeutics Holdings Inc. CRXT | ARMISTICE CAPITAL LLC | 2,452,376 9.990% | 2,452,376 (New Position) | View |
| 2022-02-14 3:24 pm Purchase | 13G | Clarus Therapeutics Holdings Inc. CRXT | CVI Investments Inc. | 264,407 1.100% | 264,407 (New Position) | View |
| 2022-02-14 11:35 am Unchanged | 13G | Clarus Therapeutics Holdings Inc. CRXT | Lighthouse Investment Partners LLC | 0 0.000% | 0 (Unchanged) | View |
| 2022-02-14 11:34 am Sale | 13G | Clarus Therapeutics Holdings Inc. CRXT | Bracebridge Capital LLC | 2,002,495 8.300% | -227,360 (-10.20%) | View |
| 2022-02-11 6:51 pm Unchanged | 13G | Clarus Therapeutics Holdings Inc. CRXT | Beryl Capital Management LLC | 0 0.000% | 0 (Unchanged) | View |
| 2022-02-08 4:28 pm Unchanged | 13G | Clarus Therapeutics Holdings Inc. CRXT | Hudson Bay Capital Management LP | 0 0.000% | 0 (Unchanged) | View |
| 2022-02-04 11:49 am Unchanged | 13G | Clarus Therapeutics Holdings Inc. CRXT | Weiss Asset Management LP | 0 0.000% | 0 (Unchanged) | View |
| 2021-12-10 5:01 pm Purchase | 13D | Clarus Therapeutics Holdings Inc. CRXT | Thomas McNerney & Partners LLC | 5,498,571 25.300% | 5,498,571 (New Position) | View |
| 2021-10-08 4:24 pm Sale | 13G | Clarus Therapeutics Holdings Inc. CRXT | Karpus Management Inc. | 0 0.000% | -770,835 (Position Closed) | View |
| 2021-09-24 06:06 am Purchase | 13G | Clarus Therapeutics Holdings Inc. CRXT | CBC SPVI Ltd | 3,602,287 16.600% | 3,602,287 (New Position) | View |
| 2021-09-21 4:18 pm Purchase | 13D | Clarus Therapeutics Holdings Inc. CRXT | H.I.G.-GPII Inc. | 5,692,381 26.200% | 5,692,381 (New Position) | View |
| 2021-09-17 4:15 pm Purchase | 13G | Clarus Therapeutics Holdings Inc. CRXT | Bracebridge Capital LLC | 2,229,855 10.300% | 2,229,855 (New Position) | View |
| 2021-08-27 2:13 pm Sale | 13G | Clarus Therapeutics Holdings Inc. CRXT | Feis Lawrence | 0 0.000% | -323,391 (Position Closed) | View |
| 2021-08-13 3:17 pm Purchase | 13G | Clarus Therapeutics Holdings Inc. CRXT | Beryl Capital Management LLC | 364,262 6.300% | 364,262 (New Position) | View |
| 2021-08-09 10:43 am Purchase | 13G | Clarus Therapeutics Holdings Inc. CRXT | Feis Lawrence | 323,391 5.570% | 323,391 (New Position) | View |
| 2021-05-10 4:05 pm Purchase | 13G | Clarus Therapeutics Holdings Inc. CRXT | Karpus Management Inc. | 770,835 10.640% | 770,835 (New Position) | View |
| 2021-02-12 11:14 am Purchase | 13G | Clarus Therapeutics Holdings Inc. CRXT | Weiss Asset Management LP | 511,800 8.810% | 511,800 (New Position) | View |